Copyright
©The Author(s) 2024.
World J Clin Oncol. Dec 24, 2024; 15(12): 1491-1500
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1491
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1491
Figure 1 Changsha human papillomavirus cervical cancer prevention screening flow chart.
Cervical cancer screening included gynecological examination, vaginal secretion examination, and high-risk human papillomavirus (HPV) type testing. Cervical cytology examination (ThinPrep cytology test) was performed in women who were positive for HPV types other than 16 and 18. Vaginal colposcopy was performed in women who were positive for HPV 16 and 18, as well as those who were positive for ThinPrep cytology test. If the results of vaginal colposcopy examination were abnormal, histopathological examination was performed. HPV: Human papillomavirus.
- Citation: Zu YE, Wang SF, Peng XX, Wen YC, Shen XX, Wang XL, Liao WB, Jia D, Liu JY, Peng XW. New cheaper human papilloma virus mass screening strategy reduces cervical cancer incidence in Changsha city: A clinical trial. World J Clin Oncol 2024; 15(12): 1491-1500
- URL: https://www.wjgnet.com/2218-4333/full/v15/i12/1491.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i12.1491